La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Carbidopa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Carbamates < Carbidopa < Carbon Monoxide Poisoning  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000615 (2014) Olivier RascolJejunal levodopa infusion in Parkinson's disease.
000753 (2013) Olivier RascolExtended-release carbidopa-levodopa in Parkinson's disease.
000775 (2013) Hélène Pouclet ; Pascal Derkinderen ; Thibaud LebouvierFoot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
000B74 (????) A. Annic ; D. Devos ; D. Seguy ; K. Dujardin ; A. Destée ; L. Defebvre[Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
000F57 (2005) Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
001138 (2003) Entacapone/levodopa/carbidopa combination tablet: Stalevo.
001366 (1999) C. Dentresangle ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. BrousolleStriatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
001789 (1991) P. Joly ; A. Lampert ; E. Thomine ; P. LauretDevelopment of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
001835 (1989) P. Rondot ; M. Ziegler ; N. Aymard ; A. TeinturierEffect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease.
001869 (1988) D. Bentué-Ferrer ; H. Allain ; J M Reymann ; O. Sabouraud ; J. Van Den DriesscheLack of pharmacokinetic influence on levodopa by bromocriptine.
001880 (1987) J L Montastruc ; P. Celsis ; A. Agniel ; J F Demonet ; B. Doyon ; M. Puel ; J P Marc-Vergnes ; A. RascolLevodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Carbidopa" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Carbidopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Carbidopa
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024